Hui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hui Li has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Guohui Liu
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5 shared publications Adriana C. Panayi
Division of Plastic Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
3 shared publicationsBobin Mi
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publicationsChenchen Yan
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publicationsHang Xue
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publicationsLang Chen
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 12 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
pH-responsive and dual-dynamically crosslinked metal-phenolic hydrogel for synergistic macrophage and Th17/Treg reprogramming in diabetic wounds
In recent years, there has been a progressive increase in the cumulative number of individuals afflicted with diabetic wounds, elevating this condition to a global public health concern of significant magnitude. The disruption of the immune microenvironment is recognized as a critical factor impeding the healing process of diabetic wounds. Nevertheless, existing research has predominantly concentrated on innate immune regulation, particularly targeting macrophages, while often overlooking adaptive immunity, which plays an equally vital role within the immune microenvironment. To address both innate and adaptive immune remodeling in diabetic wounds, the CSp-OxD@Cu 2+ /G hydrogel system has been developed. This system features a dual-dynamically crosslinked structure formed through Schiff base and borate ester bonds, with Cu 2+ /G nanoparticles generated via the chelation of guaiacol with copper ions. Upon application to diabetic wounds, the hydrogel system’s self-healing and adhesive properties provide an effective physical barrier. Concurrently, the borate ester bonds gradually respond to H + in the local environment, dissociating and facilitating the slow release of Cu 2+ /G nanoparticles, thereby reprogramming macrophages and Th17/Treg cells to concurrently regulate both innate and adaptive immune processes. This therapeutic system, characterized by its comprehensive immune regulatory effects, offers a novel platform for the management of diabetic wounds. Graphical Abstract
- 12 January 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Top Cited PapersOpen AccesspH-responsive and dual-dynamically crosslinked metal-phenolic hydrogel for synergistic macrophage and Th17/Treg reprogramming in diabetic wounds
In recent years, there has been a progressive increase in the cumulative number of individuals afflicted with diabetic wounds, elevating this condition to a global public health concern of significant magnitude. The disruption of the immune microenvironment is recognized as a critical factor impeding the healing process of diabetic wounds. Nevertheless, existing research has predominantly concentrated on innate immune regulation, particularly targeting macrophages, while often overlooking adaptive immunity, which plays an equally vital role within the immune microenvironment. To address both innate and adaptive immune remodeling in diabetic wounds, the CSp-OxD@Cu 2+ /G hydrogel system has been developed. This system features a dual-dynamically crosslinked structure formed through Schiff base and borate ester bonds, with Cu 2+ /G nanoparticles generated via the chelation of guaiacol with copper ions. Upon application to diabetic wounds, the hydrogel system’s self-healing and adhesive properties provide an effective physical barrier. Concurrently, the borate ester bonds gradually respond to H + in the local environment, dissociating and facilitating the slow release of Cu 2+ /G nanoparticles, thereby reprogramming macrophages and Th17/Treg cells to concurrently regulate both innate and adaptive immune processes. This therapeutic system, characterized by its comprehensive immune regulatory effects, offers a novel platform for the management of diabetic wounds. Graphical Abstract
- Open Access
- 25 October 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-18
Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1
Background: Postmenopausal bone loss, mainly caused by excessive bone resorption mediated by osteoclasts, has become a global public health burden. Metformin, a hypoglycemic drug, has been reported to have beneficial effects on maintaining bone health. However, the role and underlying mechanism of metformin in ovariectomized (OVX)-induced bone loss is still vague. Results: In this study, we demonstrated for the first time that metformin administration alleviated bone loss in postmenopausal women and ovariectomized mice, based on reduced bone resorption markers, increased bone mineral density (BMD) and improvement of bone microstructure. Then, osteoclast precursors administered metformin in vitro and in vivo were collected to examine the differentiation potential and autophagical level. The mechanism was investigated by infection with lentivirus-mediated BNIP3 or E2F1 overexpression. We observed a dramatical inhibition of autophagosome synthesis and osteoclast formation and activity. Treatment with RAPA, an autophagy activator, abrogated the metformin-mediated autophagy downregulation and inhibition of osteoclastogenesis. Additionally, overexpression of E2F1 demonstrated that reduction of OVX-upregulated autophagy mediated by metformin was E2F1 dependent. Mechanistically, metformin-mediated downregulation of E2F1 in ovariectomized mice could downregulate BECN1 and BNIP3 levels, which subsequently perturbed the binding of BECN1 to BCL2. Furthermore, the disconnect between BECN1 and BCL2 was shown by BNIP3 overexpression. Conclusion: In summary, we demonstrated the effect and underlying mechanism of metformin on OVX-induced bone loss, which could be, at least in part, ascribed to its role in downregulating autophagy during osteoclastogenesis via E2F1-dependent BECN1 and BCL2 downregulation, suggesting that metformin or E2F1 inhibitor is a potential agent against postmenopausal bone loss.
- 25 October 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-18
Open AccessMetformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1
Background: Postmenopausal bone loss, mainly caused by excessive bone resorption mediated by osteoclasts, has become a global public health burden. Metformin, a hypoglycemic drug, has been reported to have beneficial effects on maintaining bone health. However, the role and underlying mechanism of metformin in ovariectomized (OVX)-induced bone loss is still vague. Results: In this study, we demonstrated for the first time that metformin administration alleviated bone loss in postmenopausal women and ovariectomized mice, based on reduced bone resorption markers, increased bone mineral density (BMD) and improvement of bone microstructure. Then, osteoclast precursors administered metformin in vitro and in vivo were collected to examine the differentiation potential and autophagical level. The mechanism was investigated by infection with lentivirus-mediated BNIP3 or E2F1 overexpression. We observed a dramatical inhibition of autophagosome synthesis and osteoclast formation and activity. Treatment with RAPA, an autophagy activator, abrogated the metformin-mediated autophagy downregulation and inhibition of osteoclastogenesis. Additionally, overexpression of E2F1 demonstrated that reduction of OVX-upregulated autophagy mediated by metformin was E2F1 dependent. Mechanistically, metformin-mediated downregulation of E2F1 in ovariectomized mice could downregulate BECN1 and BNIP3 levels, which subsequently perturbed the binding of BECN1 to BCL2. Furthermore, the disconnect between BECN1 and BCL2 was shown by BNIP3 overexpression. Conclusion: In summary, we demonstrated the effect and underlying mechanism of metformin on OVX-induced bone loss, which could be, at least in part, ascribed to its role in downregulating autophagy during osteoclastogenesis via E2F1-dependent BECN1 and BCL2 downregulation, suggesting that metformin or E2F1 inhibitor is a potential agent against postmenopausal bone loss.
- Open Access
- 22 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 5564604
Clinical Application Study of Minimally Invasive Double‐Reverse Traction in Complex Tibial Plateau Fractures
The aim of this study was to evaluate the clinical application of double-reverse traction for minimally invasive reduction of complex tibial plateau fractures. A retrospective analysis was performed to identify all patients admitted to the Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, from March 2017 to December 2019 with Schatzker type VI tibial plateau fractures. 12 patients were identified (7 men and 5 women) with an average age of (39-58) years old. All patients were treated with double-reverse traction and closed reduction. After the fracture was reduced, the bone plate was fixed by percutaneous minimally invasive implantation. Outcomes assessed in this study include operation time and intraoperative blood loss. Imaging was performed during the postoperative follow-up, and functional recovery was evaluated at the final follow-up according to the Hospital for Special Surgery (HSS) score and the International Knee Joint Literature Committee (IKDC) functional score. Patients were followed up for (8-15) months. The average operation time was (35-120) minutes, and the average intraoperative blood loss was (60-200) mL. The Rasmussen imaging score was either excellent or good in all cases. The knee joint HSS score was (79-90) points, and the IKDC score was (75-90) points. No complications, such as wound infection, incision disunion, loosening of internal fixation, and internal fixation failure, occurred. In the treatment of Schatzker VI type complex tibial plateau fracture, the dual-reverse traction minimally invasive technique has the advantages of safety and effectiveness, less soft tissue injury, and allowing early joint movement, which is worthy of clinical promotion.
- 22 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 5564604
Open AccessClinical Application Study of Minimally Invasive Double‐Reverse Traction in Complex Tibial Plateau Fractures
The aim of this study was to evaluate the clinical application of double-reverse traction for minimally invasive reduction of complex tibial plateau fractures. A retrospective analysis was performed to identify all patients admitted to the Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, from March 2017 to December 2019 with Schatzker type VI tibial plateau fractures. 12 patients were identified (7 men and 5 women) with an average age of (39-58) years old. All patients were treated with double-reverse traction and closed reduction. After the fracture was reduced, the bone plate was fixed by percutaneous minimally invasive implantation. Outcomes assessed in this study include operation time and intraoperative blood loss. Imaging was performed during the postoperative follow-up, and functional recovery was evaluated at the final follow-up according to the Hospital for Special Surgery (HSS) score and the International Knee Joint Literature Committee (IKDC) functional score. Patients were followed up for (8-15) months. The average operation time was (35-120) minutes, and the average intraoperative blood loss was (60-200) mL. The Rasmussen imaging score was either excellent or good in all cases. The knee joint HSS score was (79-90) points, and the IKDC score was (75-90) points. No complications, such as wound infection, incision disunion, loosening of internal fixation, and internal fixation failure, occurred. In the treatment of Schatzker VI type complex tibial plateau fracture, the dual-reverse traction minimally invasive technique has the advantages of safety and effectiveness, less soft tissue injury, and allowing early joint movement, which is worthy of clinical promotion.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Exosomes Derived from Bone Mesenchymal Stem Cells Alleviate Compression‐Induced Nucleus Pulposus Cell Apoptosis by Inhibiting Oxidative Stress
Oxidative stress is relevant in compression‐induced nucleus pulposus (NP) cell apoptosis and intervertebral disc (IVD) degeneration. Exosomes derived from bone mesenchymal stem cells (BMSCs‐Exos) are key secretory products of MSCs, with important roles in tissue regeneration. This research is aimed at studying the protective impact of BMSCs‐Exos on NP cell apoptosis caused by compression and investigating the underlying mechanisms. Our results indicated that we isolated BMSCs successfully. Exosomes were isolated from the BMSCs and found to alleviate the inhibitory effect that compression has on proliferation and viability in NP cells, decreasing the toxic effects of compression‐induced NP cells. AnnexinV/PI double staining and TUNEL assays indicated that the BMSCs‐Exos reduced compression‐induced apoptosis. In addition, our research found that BMSCs‐Exos suppressed compression‐mediated NP oxidative stress by detecting the ROS and malondialdehyde level. Furthermore, BMSCs‐Exos increased the mitochondrial membrane potential and alleviated compression‐induced mitochondrial damage. These results indicate that BMSCs‐Exos alleviate compression‐mediated NP apoptosis by suppressing oxidative stress, which may provide a promising cell‐free therapy for treating IVD degeneration.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1)
Open AccessExosomes Derived from Bone Mesenchymal Stem Cells Alleviate Compression‐Induced Nucleus Pulposus Cell Apoptosis by Inhibiting Oxidative Stress
Oxidative stress is relevant in compression‐induced nucleus pulposus (NP) cell apoptosis and intervertebral disc (IVD) degeneration. Exosomes derived from bone mesenchymal stem cells (BMSCs‐Exos) are key secretory products of MSCs, with important roles in tissue regeneration. This research is aimed at studying the protective impact of BMSCs‐Exos on NP cell apoptosis caused by compression and investigating the underlying mechanisms. Our results indicated that we isolated BMSCs successfully. Exosomes were isolated from the BMSCs and found to alleviate the inhibitory effect that compression has on proliferation and viability in NP cells, decreasing the toxic effects of compression‐induced NP cells. AnnexinV/PI double staining and TUNEL assays indicated that the BMSCs‐Exos reduced compression‐induced apoptosis. In addition, our research found that BMSCs‐Exos suppressed compression‐mediated NP oxidative stress by detecting the ROS and malondialdehyde level. Furthermore, BMSCs‐Exos increased the mitochondrial membrane potential and alleviated compression‐induced mitochondrial damage. These results indicate that BMSCs‐Exos alleviate compression‐mediated NP apoptosis by suppressing oxidative stress, which may provide a promising cell‐free therapy for treating IVD degeneration.
- Open Access
- 7 May 2020
- Published by Impact Journals, LLC in Aging
- Vol. 12 (9) , 7619-7625
Preventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan’s experience
Hip fractures in the elderly account for more than half of osteoporotic fractures and represent a substantial economic and social burden. Novel coronavirus pneumonia (COVID-19), which began to spread in December 2019, has created challenges in the management of elderly hip fracture patients, not only by influencing the choice of operation and postoperative rehabilitation methods, but also by generating new risks for the medical staff. During this period, our infection and orthopedic treatment unit in the center of the epidemic area effectively treated 82 elderly patients with hip fracture, and no cross-infection occurred. Therefore, our experience in prevention and treatment is worth recommending to frontline anti-epidemic personnel.
- 7 May 2020
- Published by Impact Journals, LLC in Aging
- Vol. 12 (9) , 7619-7625
Open AccessPreventive strategy for the clinical treatment of hip fractures in the elderly during the COVID-19 outbreak: Wuhan’s experience
Hip fractures in the elderly account for more than half of osteoporotic fractures and represent a substantial economic and social burden. Novel coronavirus pneumonia (COVID-19), which began to spread in December 2019, has created challenges in the management of elderly hip fracture patients, not only by influencing the choice of operation and postoperative rehabilitation methods, but also by generating new risks for the medical staff. During this period, our infection and orthopedic treatment unit in the center of the epidemic area effectively treated 82 elderly patients with hip fracture, and no cross-infection occurred. Therefore, our experience in prevention and treatment is worth recommending to frontline anti-epidemic personnel.